SRST2: a new tool for genomic epidemiology
In this Q&A, Michael Inouye and Kathryn Holt, authors of a Software article recently published in Genome Medicine, tell us about the development of the… Read more »
Senior Editor at Genome Medicine
Latest posts by Andreia Cunha (see all)
- SRST2: a new tool for genomic epidemiology - 18th December 2014
- Less talking and more doing: the return of secondary genomic findings to patients - 29th May 2014
- Call for papers: Genome Medicine announces a new series on Participatory Medicine - 23rd July 2013
Less talking and more doing: the return of secondary genomic findings to patients
A study published today in Genome Medicine describes a framework for returning ‘secondary’ or ‘incidental’ genomic findings to patients. We take a look… Read more »
Call for papers: Genome Medicine announces a new series on Participatory Medicine
Later this year, Genome Medicine will publish a new thematic series focusing on Participatory Medicine. This article collection will highlight how the… Read more »
Anti-TNF-alpha therapeutics in chronic inflammatory diseases – seeing in the dark
Multiple diseases are covered by the umbrella of poorly understood etiology coupled to an exaggerated or misguided inflammatory response. At first sight, it… Read more »
In this issue of Genome Medicine: disease in the microbial jungle, a technology for target enrichment, genomics of osteoporosis and chronic lymphocytic leukemia, and more…
The May issue of Genome Medicine features two articles that highlight the role of microbes in human health and disease as part of a recently launched thematic… Read more »
With a little help from your family: advances in non-invasive prenatal diagnosis
Accurate prenatal diagnosis is important to guide pregnancy and birth management, therapeutic strategies, and future family planning, but invasive diagnostic… Read more »
Not a mixed bag: redefining syndromes associated with ASXL gene mutations
Bohring-Opitz syndrome is a clinically heterogeneous developmental condition characterized by feeding difficulties, severe developmental delays, a smaller than… Read more »
Return of incidental genetic findings: guidelines for clinical trials
The decrease in cost and increase in efficiency of genome-scale studies means we can enjoy fast-paced generation of genomic data. In the clinic, this growth has… Read more »
miRNA biomarkers in osteosarcoma: crossing a new bridge
Osteosarcoma is the most common type of bone tumor, but the lack of good biomarkers to predict the outcome of standard treatment has so far prevented patient… Read more »
Cystic fibrosis modifier genes: the last refuge of the complex
Cystic fibrosis is a rare but lethal autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.… Read more »